Abstract
Objective To evaluate the relationship of serous retinal detachment (SRD) and treatment outcome after intravitreal Avastin injection in patients with macular edema due to branch retinal vein occlusion (BRVO).Methods A retrospective case-observation study.The clinical data of 59 patients (59 eyes) from with macular edema secondary to BRVO who received intravitreal Avastin injection (1.25mg/0.05mL) were included in this study.All the patients did not receive other any therapy prior to the injection of Avastin.Clinical indexes included best corrected visual acuity (BC-VA),intraocular pressure,slit-lamp examination,stereoscopic biomicroscopy examination and fundus photography,optical coherence tomography (OCT) before injection and 1 month,3 months after initial injection.Fluorescein fundus angiography (FFA) was performed prior to injection and 3 months after initial injection.Patients were separated into 2 groups:SRD (+) and SRD (-),according to the presence or absence of SRD on OCT.Results SRD was found in 22 patients (37.29%).The age was younger in the SRD (+) group than in the SRD (-) group (P <0.05).The baseline central subfield macular thickness (CSMT) was significantly thicker in the SRD (+) group than in the SRD (-) group (P <0.001).One month and 3 months after initial intravitreal injection of Avastin,greater reductions in CSMT change from baseline were observed in the SRD (+) group than in the SRD (-) group (P <0.001).Three months after the initial injection,a grater improvement of BCVA was also found in the SRD (+) group than in the SRD (-) group (P <0.05).Conclusions Patients with SRD has greater reductions in CSMT and improvements of BCVA after intravitreal Avastin injection in patients with macular edema due to BRVO. Key words: Avastin; Branch retinal vein occlusion; Macular edema; Serous retinal detachment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.